000403.SZ

Pacific Shuanglin Bio-pharmacy Co., LTD [000403.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

000403.SZ Stock Summary

Earnings have grown 21.98% per last year.

Top 10 Correlated ETFs

000403.SZ

Top 10 Correlated Stocks

000403.SZ

In the News

000403.SZ Financial details

Company Rating

Market Cap

20.62B

Income

563.79M

Revenue

2.29B

Book val./share

Cash/share

Dividend

0.08

Dividend %

0.31%

Employees

2.09K

Optionable

Shortable

Yes

Earnings

23 Aug 2023

P/E

33.76

Forward P/E

PEG

8.17

P/S

8.28

P/B

2.67

P/C

P/FCF

-890.92

Quick Ratio

2.5

Current Ratio

3.64

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.78

EPS next Y

EPS next Q

EPS this Y

45.45%

EPS next Y

EPS next 5Y

EPS last 5Y

39.77%

Revenue last 5Y

22.84%

Revenue Q/Q

48.53%

EPS Q/Q

108.33%

SMA20

1.19%

SMA50

3.12%

SMA100

2.26%

Inst Own

Inst Trans

ROA

ROE

ROC

0.09%

Gross Margin

52%

Oper. Margin

28%

Profit Margin

25%

Payout

12%

Shs Outstand

Shs Float

Target Price

52W Range

17.49-31.25

52W High

-29.35%

52W Low

+28.82%

RSI

43.67

Rel Volume

1.85

Avg Volume

6.05M

Volume

11.19M

Perf Week

-4.16%

Perf Month

-0.82%

Perf Quarter

-1.31%

Perf Half Y

-5.36%

Beta

0.471

Volatility

0.29%, 1.17%

Prev Close

-0.64%

Price

21.9

Change

0.92%

000403.SZ Financial Performance

000403.SZ Dividend History

000403.SZ Frequently Asked Questions

What is Pacific Shuanglin Bio-pharmacy Co., LTD stock symbol ?

Pacific Shuanglin Bio-pharmacy Co., LTD is a CN stock and trading under the symbol 000403.SZ

What is Pacific Shuanglin Bio-pharmacy Co., LTD stock quote today ?

Pacific Shuanglin Bio-pharmacy Co., LTD stock price is $21.9 today.

Is Pacific Shuanglin Bio-pharmacy Co., LTD stock public?

Yes, Pacific Shuanglin Bio-pharmacy Co., LTD is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 6.05M
Market Capitalization 20.62B
Employee 2.09K
CEO Mr. Hua Gang Yuan
Headquarters Taiyuan,CN
IPO Date 2013-02-08
Website https://www.slbiop.com

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.